Ertumaxomab

WikiDoc Resources for Ertumaxomab
Articles
Most recent articles on Ertumaxomab Most cited articles on Ertumaxomab Review articles on Ertumaxomab Articles on Ertumaxomab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ertumaxomab Images of Ertumaxomab Photos of Ertumaxomab Podcasts & MP3s on Ertumaxomab Videos on Ertumaxomab
Evidence Based Medicine
Cochrane Collaboration on Ertumaxomab Bandolier on Ertumaxomab TRIP on Ertumaxomab
Clinical Trials
Ongoing Trials on Ertumaxomab at Clinical Trials.gov Trial results on Ertumaxomab Clinical Trials on Ertumaxomab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ertumaxomab NICE Guidance on Ertumaxomab NHS PRODIGY Guidance FDA on Ertumaxomab CDC on Ertumaxomab
Books
Books on Ertumaxomab
News
Ertumaxomab in the news Be alerted to news on Ertumaxomab News trends on Ertumaxomab
Commentary
Blogs on Ertumaxomab
Definitions
Definitions of Ertumaxomab
Patient Resources / Community
Patient resources on Ertumaxomab Discussion groups on Ertumaxomab Patient Handouts on Ertumaxomab Directions to Hospitals Treating Ertumaxomab Risk calculators and risk factors for Ertumaxomab
Healthcare Provider Resources
Symptoms of Ertumaxomab Causes & Risk Factors for Ertumaxomab Diagnostic studies for Ertumaxomab Treatment of Ertumaxomab
Continuing Medical Education (CME)
CME Programs on Ertumaxomab
International
Ertumaxomab en Espanol Ertumaxomab en Francais
Business
Ertumaxomab in the Marketplace Patents on Ertumaxomab
Experimental / Informatics
List of terms related to Ertumaxomab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Ertumaxomab (marketed under the brand name Rexomun®) is a rat-murine hybrid monoclonal antibody which it's used to treat some cancers.

Template:Rat-murinehybridmonoclonals Template:SIB Template:WH Template:WS